Boston Scientific announced an analysis of 989 patients with hepatocellular carcinoma (HCC) from the PROACTIF prospective ...

InVera Medical announced 12-month results from its pilot clinical study of the InVera infusion device for the treatment of ...

Efemoral Medical announced long-term results of the first 40 patients treated in the EFEMORAL I first-in-human (FIH) clinical ...

Gore & Associates announced new 12-month findings from the global GORE VIABAHN FORTEGRA Venous Stent IVC trial, which evaluat ...

In this retrospective analysis, Zil-E-Ali et al found that patients with government-funded insurance who underwent urgent or ...

Sonorous Neurovascular, a developer of solutions for cerebral venous diseases and neurovascular interventions, announced that ...

Gore & Associates announced that its Excluder thoracoabdominal branch endoprosthesis (TAMBE) received CE Mark approval earlie ...

Translating the 2026 PE guideline recommendations into practice to enhance decision-making, streamline care pathways, and ...

Adopting next-generation technologies can help centers stay at the cutting edge of innovative care. However, the burden of ...

Experience at a large, urban academic institution with a focus on comprehensive clinical practice, multidisciplinary ...

Exploring the role of hypertension centers of excellence, referral pathways, strategies to optimize care for resistant ...

We spoke with three Principal Investigators (PIs) from the AAA-SHAPE pivotal trial—Dr. Linda Harris, Dr. Caitlin Hicks, and ...